Inozyme Pharma, Inc.

CIK 1693011 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inozyme Pharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 27, 2025SCHEDULE 13D/A0000950170-25-111753
Aug 14, 2025SCHEDULE 13G/A0000935836-25-000513
Aug 13, 2025SCHEDULE 13G/A0001172661-25-003156
Aug 12, 2025SCHEDULE 13G/A0000902664-25-003501
Jul 17, 2025SCHEDULE 13G/A0002052113-25-003071
Jul 11, 202515-12G0001193125-25-157809
Jul 3, 202540000950170-25-094093
Jul 3, 202540000950170-25-094089
Jul 3, 202540000950170-25-094091
Jul 3, 202540000950170-25-094103
Jul 3, 202540000950170-25-094098
Jul 3, 202540000950170-25-094096
Jul 1, 2025S-8 POS0001193125-25-153635
Jul 1, 2025EFFECT9999999995-25-002117
Jul 1, 2025SC TO-T/A0001193125-25-153574
Jul 1, 2025S-8 POS0001193125-25-153657
Jul 1, 2025SC 14D9/A0001193125-25-153577
Jul 1, 2025POS AM0001193125-25-153585
Jul 1, 20258-K0001193125-25-153582
Jul 1, 2025S-8 POS0001193125-25-153654
Jul 1, 2025POS AM0001193125-25-153591
Jul 1, 2025S-8 POS0001193125-25-153632
Jul 1, 202525-NSE0001354457-25-000600
Jul 1, 2025S-8 POS0001193125-25-153651
Jul 1, 2025S-8 POS0001193125-25-153636